What are the ACOG criteria for interpreting the 2‑hour plasma glucose value on a postpartum oral glucose tolerance test in women with prior gestational diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Postpartum OGTT Criteria for Women with Prior GDM

Women with a history of gestational diabetes should be screened at 6-12 weeks postpartum using a 75-g oral glucose tolerance test (OGTT) with standard nonpregnancy diagnostic criteria, NOT pregnancy-specific thresholds.

Standard Nonpregnancy Diagnostic Criteria for the 2-Hour Value

The 2-hour plasma glucose value on the postpartum OGTT should be interpreted using these thresholds 1:

  • Diabetes: 2-hour glucose ≥200 mg/dL (11.1 mmol/L)
  • Impaired glucose tolerance (prediabetes): 2-hour glucose 140-199 mg/dL (7.8-11.0 mmol/L)
  • Normal: 2-hour glucose <140 mg/dL (7.8 mmol/L)

Additionally, evaluate the fasting value:

  • Diabetes: Fasting glucose ≥126 mg/dL (7.0 mmol/L)
  • Impaired fasting glucose (prediabetes): Fasting glucose 100-125 mg/dL (5.6-6.9 mmol/L)
  • Normal: Fasting glucose <100 mg/dL (5.6 mmol/L)

Critical Distinction: Pregnancy vs. Postpartum Criteria

Do not use the pregnancy GDM diagnostic thresholds postpartum. During pregnancy, the 2-hour cutoff for GDM diagnosis is 153 mg/dL (one-step) or 155 mg/dL (two-step Carpenter/Coustan), but these values are specifically calibrated for pregnancy physiology and adverse pregnancy outcomes 2.

Postpartum, you are screening for persistent diabetes or prediabetes using standard WHO/ADA nonpregnancy criteria because insulin resistance normalizes dramatically after delivery 1.

Confirmation Requirements

Important caveat: If diabetes is diagnosed based on a single abnormal OGTT value (either fasting ≥126 mg/dL OR 2-hour ≥200 mg/dL), the 2022 ADA criteria now require confirmation with a second abnormal test on a different day in the absence of unequivocal hyperglycemia 3. If both the fasting AND 2-hour values meet diabetes criteria on the same OGTT, diabetes is confirmed without repeat testing 3.

Timing Considerations

  • Optimal timing: 6-12 weeks postpartum 2, 1, 4
  • Avoid immediate postpartum testing (within 48 hours): Recent evidence shows inpatient testing yields falsely elevated rates of glucose intolerance and diabetes diagnoses, particularly on postpartum day 1 5
  • Do not use A1C at the 6-12 week postpartum visit, as it may be artificially lowered by increased red blood cell turnover during pregnancy, blood loss at delivery, or the preceding glucose profile 1, 3

Long-Term Follow-Up Algorithm

After the initial postpartum OGTT 2, 3:

  1. If normal: Repeat screening every 1-3 years using any standard test (A1C, fasting glucose, or OGTT)
  2. If prediabetes diagnosed: Offer intensive lifestyle interventions or metformin to prevent progression to diabetes 2, 3
  3. Before any future pregnancy: Screen again for diabetes to identify women who have progressed since the last pregnancy 3

The lifetime risk of developing type 2 diabetes after GDM is substantial—approximately 50-60% within 10-20 years—making this long-term surveillance critical 6, 3.

Related Questions

When and how should a postpartum oral glucose tolerance test (OGTT) be performed for women who had gestational diabetes?
What are the American College of Obstetricians and Gynecologists (ACOG) diagnostic thresholds for the 2‑hour oral glucose tolerance test for gestational diabetes?
In a 35‑week pregnant woman with a 3 cm head‑abdomen discrepancy in a fetus at the 22nd percentile for weight and elevated maternal daily blood‑glucose values, should she be diagnosed with gestational diabetes now?
What are the latest guidelines and comprehensive outpatient and primary care management for type 1, type 2, and gestational diabetes mellitus, including diagnostic criteria and complete treatment according to the Brazilian Diabetes Society (SBD) and the Brazilian Society of Endocrinology and Metabolism (SBEM)?
When should an oral glucose tolerance test be performed to screen for gestational diabetes mellitus in a 29-year-old pregnant woman at 12 weeks gestation with no prior diabetes or risk factors?
What ICD‑10‑CM diagnosis code should be used for an elevated serum folate level?
What are the American College of Obstetricians and Gynecologists (ACOG) diagnostic thresholds for the 2‑hour oral glucose tolerance test for gestational diabetes?
What is the recommended memantine dosing and monitoring for treating excoriation disorder (skin‑picking disorder) after behavioral therapy and SSRI trials have failed?
How does a genetic predisposition such as familial hypercholesterolemia affect elevated low‑density lipoprotein cholesterol, and what is the recommended management?
Should a patient with chronic irritable bowel syndrome‑predominant constipation use polyethylene glycol 3350 (Miralax) for constipation?
For a patient seeking optimal improvement in cholesterol, liver health, cardiovascular and renal protection, and insulin sensitivity, is tirzepatide or retatrutide the preferred therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.